pathway,nums,percent,pvalue,,
Spliceosome,98,96.08,0,,
DNA replication,33,100,0,,
Ribosome biogenesis in eukaryotes,51,91.07,0,,
"Spliceosome, U4/U6.U5 tri-snRNP",18,85.71,0,,
Mismatch repair,22,100,0,,
"Spliceosome, U2-snRNP",18,94.74,0,,
Base excision repair,30,90.91,0,,
Nuclear pore complex,26,86.67,0,,
"Spliceosome, 35S U5-snRNP",22,84.62,0,,
RNA polymerase,17,77.27,0,,
Homologous recombination,30,96.77,0,,
mRNA surveillance pathway,61,91.04,0,,
BRCA1-associated genome surveillance complex (BASC),14,93.33,0,,
Fanconi anemia pathway,29,90.62,0.0001,,
Nucleocytoplasmic transport,79,95.18,0.0001,,
RNA degradation,38,82.61,0.0001,,
RNA transport,111,96.52,0.0003,,
Polycomb repressive complex,61,96.83,0.0004,,
Pyrimidine metabolism,65,91.55,0.0005,,
"RNA polymerase II, eukaryotes",6,100,0.0006,,
"Spliceosome, U1-snRNP",8,88.89,0.0007,,
Sm core complex,7,100,0.001,,
MCM complex,6,100,0.0017,,
Aminoacyl-tRNA biosynthesis,22,75.86,0.0047,,
"Aminoacyl-tRNA biosynthesis, eukaryotes",18,72,0.0052,,
Nucleotide excision repair,38,90.48,0.0054,,
"RNA polymerase I, eukaryotes",7,100,0.0068,,
"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",6,100,0.0096,,
"RNA polymerase III, eukaryotes",10,90.91,0.01,,
Cell cycle - G2/M transition,7,100,0.0105,,
FA core complex,6,100,0.0111,,
Purine metabolism,89,92.71,0.0132,,
Cell cycle,128,98.46,0.0138,,
RF-C complex,5,100,0.0137,,
Exon junction complex (EJC),13,81.25,0.0141,,
"Exosome, eukaryotes",6,100,0.015,,
DNA damage-induced cell cycle checkpoints,7,100,0.0146,,
Systemic lupus erythematosus,8,66.67,0.0174,,
Cytochrome bc1 complex,7,100,0.017,,
Basal transcription factors,36,92.31,0.0175,,
"Alanine, aspartate and glutamate metabolism",15,65.22,0.0254,,
Non-homologous end-joining,6,100,0.0361,,
2-Oxocarboxylic acid metabolism,20,100,0.0423,,
Herpes simplex infection,88,93.62,0.0512,,
Origin recognition complex,6,100,0.0603,,
Staphylococcus aureus infection,12,85.71,0.0606,,
One carbon pool by folate,11,84.62,0.0995,,
Shelterin complex,5,100,0.123,,
Nicotine addiction,3,60,0.1245,,
Fructose and mannose metabolism,3,16.67,0.1431,,
Lipoic acid metabolism,11,100,0.1538,,
Glyoxylate and dicarboxylate metabolism,12,60,0.1807,,
"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",5,45.45,0.1807,,
"Spliceosome, Prp19/CDC5L complex",8,100,0.1851,,
Arginine and proline metabolism,11,40.74,0.2211,,
Tyrosine metabolism,17,100,0.2184,,
"F-type ATPase, eukaryotes",2,33.33,0.2414,,
Phenylalanine metabolism,10,100,0.2526,,
Triacylglycerol biosynthesis,9,100,0.2963,,
Biosynthesis of amino acids,29,69.05,0.3177,,
Proteasome,20,66.67,0.3129,,
Nitrogen metabolism,5,83.33,0.3147,,
Methionine degradation,4,66.67,0.3112,,
Antifolate resistance,12,80,0.3097,,
Cysteine and methionine metabolism,22,78.57,0.3108,,
Progesterone-mediated oocyte maturation,55,82.09,0.3557,,
Viral life cycle - HIV-1,26,76.47,0.3561,,
TREX complex,8,100,0.3513,,
Ribosome,87,87,0.3497,,
Drug metabolism - other enzymes,30,75,0.3964,,
Cytosolic DNA-sensing pathway,27,84.38,0.3924,,
Citrate cycle (TCA cycle),21,100,0.4146,,
Drug metabolism - cytochrome P450,7,30.43,0.4128,,
"Citrate cycle (TCA cycle, Krebs cycle)",17,100,0.4269,,
Glycerolipid metabolism,15,60,0.4307,,
"C1-unit interconversion, eukaryotes",6,100,0.4337,,
Glycolysis / Gluconeogenesis,16,51.61,0.4335,,
"Ribosome, eukaryotes",63,95.45,0.4442,,
Thyroid cancer,11,52.38,0.4745,,
Carbon metabolism,46,67.65,0.4698,,
African trypanosomiasis,5,35.71,0.4718,,
Retinol metabolism,6,60,0.4764,,
Huntington's disease,74,68.52,0.4963,,
Primary immunodeficiency,5,71.43,0.5052,,
Nucleotide metabolism,40,85.11,0.5508,,
Oocyte meiosis,63,80.77,0.5584,,
Amyotrophic lateral sclerosis,152,78.76,0.5608,,
NOD-like receptor signaling pathway,48,50.53,0.5933,,
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",11,100,0.5904,,
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,6,100,0.6167,,
BER complex,8,100,0.6253,,
Coronavirus disease - COVID-19,99,84.62,0.6441,,
Transcriptional misregulation in cancer,86,93.48,0.641,,
Chemical carcinogenesis - receptor activation,66,64.71,0.658,,
Chemical carcinogenesis - reactive oxygen species,56,45.9,0.6782,,
Inositol phosphate metabolism,22,47.83,0.6726,,
Methionine salvage pathway,5,100,0.6868,,
"Proteasome, 19S regulatory particle (PA700)",6,50,0.6938,,
"Glycine, serine and threonine metabolism",15,75,0.7231,,
Signaling pathways regulating pluripotency of stem cells,61,77.22,0.7517,,
Holo-TFIIH complex,10,100,0.7459,,
Metabolic pathways,527,91.02,0.7421,,
"Gluconeogenesis, oxaloacetate => fructose-6P",3,37.5,0.7451,,
"Leucine degradation, leucine => acetoacetate + acetyl-CoA",9,100,0.7442,,
Prion diseases,10,47.62,0.7475,,
"O-glycan biosynthesis, mucin type core",4,40,0.7824,,
Mucin type O-glycan biosynthesis,4,33.33,0.7854,,
Survival motor neuron (SMN) complex,8,100,0.8022,,
beta-Alanine metabolism,19,100,0.8394,,
Cell adhesion molecules,28,63.64,0.8768,,
"Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate",6,100,0.8806,,
Cell adhesion molecules (CAMs),27,65.85,0.8807,,
Endometrial cancer,22,64.71,0.8834,,
IL-17 signaling pathway,20,50,0.9051,,
Bladder cancer,16,66.67,0.8979,,
Glutathione metabolism,26,65,0.9016,,
Ubiquinone and other terpenoid-quinone biosynthesis,3,60,0.8971,,
Activin signaling,6,100,0.9079,,
Legionellosis,17,70.83,0.9388,,
Pyruvate metabolism,16,55.17,0.9312,,
Fat digestion and absorption,12,100,0.9324,,
Parkinson's disease,32,42.67,0.933,,
Selenocompound metabolism,11,100,0.9336,,
Biosynthesis of cofactors,49,68.06,0.9433,,
"NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria",8,100,0.9411,,
Antigen processing and presentation,15,62.5,0.9359,,
Central carbon metabolism in cancer,21,50,0.9407,,
Colorectal cancer,36,64.29,0.9747,,
Amyotrophic lateral sclerosis (ALS),18,58.06,0.9718,,
Huntington disease,121,75.16,0.9653,,
Acute myeloid leukemia,29,72.5,0.9731,,
"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",8,88.89,0.9714,,
Thyroid hormone signaling pathway,45,61.64,0.9677,,
"Proteasome, 20S core particle",9,100,0.963,,
Immunoproteasome,14,100,0.9817,,
Longevity regulating pathway - multiple species,16,41.03,1,,
Oxidative phosphorylation,29,42.03,1,,
Hepatitis C,75,91.46,1,,
Parkinson disease,83,58.45,1,,
Leishmaniasis,12,37.5,1,,
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,11,100,1,,
Aldosterone-regulated sodium reabsorption,7,35,1,,
Breast cancer,56,77.78,1,,
Peroxisome,10,25,1,,
ErbB signaling pathway,22,43.14,1,,
Wnt signaling,8,61.54,1,,
Neuroactive ligand-receptor interaction,21,43.75,1,,
Prostate cancer,54,90,1,,
Histidine metabolism,11,100,1,,
Folate biosynthesis,11,100,1,,
Mitophagy - animal,17,39.53,1,,
Basal cell carcinoma,17,70.83,1,,
Hippo signaling pathway -multiple species,5,29.41,1,,
Hippo signaling,5,41.67,1,,
Hippo signaling pathway - multiple species,5,29.41,1,,
Arginine biosynthesis,9,100,1,,
"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",7,53.85,1,,
Notch signaling pathway,22,66.67,1,,
Type II diabetes mellitus,7,38.89,1,,
"Glycolysis, core module involving three-carbon compounds",2,33.33,0.9995,,
N-glycan precursor biosynthesis,4,57.14,0.9965,,
APC/C complex,12,100,1,,
Gastric cancer,57,79.17,1,,
Thiamine metabolism,7,100,1,,
Proximal tubule bicarbonate reclamation,14,100,0.9984,,
NF-kappa B signaling pathway,30,56.6,0.9951,,
Complement and coagulation cascades,6,28.57,1,,
Notch signaling,3,37.5,0.9977,,
Biosynthesis of nucleotide sugars,7,31.82,1,,
JAK-STAT signaling pathway,33,55,1,,
Lipid and atherosclerosis,65,65.66,1,,
Jak-STAT signaling pathway,33,57.89,1,,
Fluid shear stress and atherosclerosis,39,46.99,1,,
Th17 cell differentiation,33,67.35,0.999,,
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",1,20,NA,,
